SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is generating buzz as its community anticipates the upcoming 4/20 cultural event, rallying around its mission to support global cannabis legalization and integrate real-world utility while proclaiming itself "like Bitcoin but way higher."

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending due to reaffirmed FY25 outlook and robust VEVYE script trends, bolstered by CVS Caremark Tier 1 formulary status. The community actively anticipates a potential short squeeze and accelerated growth, further fueled by a Deloitte audit upgrade signaling big-cap ambitions within the ophthalmic sector.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is trending as community discussion focuses on the recent commercial launch and ramp-up of its gene therapy, ZEVASKYN, highlighted by an effective J-code and expanding treatment capacity. Despite strong institutional ownership and analyst price targets, the stock is seen by many as deeply undervalued, trading near its cash value, while also attracting significant short interest, with investors anticipating sustained revenue growth and pipeline catalysts.

USDX (Website: usdx.money | Twitter: @StablesLabs) is a synthetic USD stablecoin designed to provide stability without relying on traditional banking infrastructure. Backed by delta-neutral positions across multiple exchanges, USDX seamlessly bridges the gap between DeFi, CeFi, and TradFi. It enables DeFi users to access traditional delta-neutral strategies executed in CeFi platforms. As a crypto-native stablecoin, USDX offers a scalable, censorship-resistant, and highly stable solution for users looking to navigate the world of decentralized finance with confidence.

USDX Stablecoin

USDX Stablecoin is trending after its significant de-pegging below $0.45, an event driven by the Balancer hack and the collapse of Stream Finance and Elixirs, which has intensified community debate over the fragility of DeFi stablecoins.

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

OPENAI CRYPTO is trending due to overwhelming community confusion and skepticism, with many users questioning its legitimacy as a potential scam and differentiating it from the actual OpenAI AI company.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF (SCHD) is gaining significant attention and showing strong resilience, often posting gains even as broader markets experience downturns, cementing its perception as a "flight to safety" asset. The community is actively discussing its consistent dividend growth and potential benefits from sector rotation away from tech, though some investors anticipate a pullback due to an extended valuation.

Realty Income Corp. is a real estate company, which engages in generating dependable monthly cash dividends from a consistent and predictable level of cash flow from operations. The company was founded by William E. Clark, Jr. and Evelyn Joan Clark in 1969 and is headquartered in San Diego, CA.

Realty Income Corp.

Realty Income (O) is trending following a Deutsche Bank upgrade and strategic partnerships signaling future growth, with community discussion focusing on its consistent monthly dividend as a defensive play and its potential for appreciation amid anticipated interest rate cuts.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is actively discussed following its recent Q3 earnings report, which highlighted a revenue beat and raised guidance but resulted in a puzzling stock dip, intensified by a prior FDA alert concerning certain product lots. The community views this as a significant undervaluation, with many anticipating a strong rebound driven by operational efficiencies, future catalysts, and persistent speculation of a potential takeover.

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers' enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.

Nutanix Inc - Ordinary Shares - Class A

Nutanix Inc 

Nutanix is trending as the company announced a significant accelerated share repurchase program, signaling confidence and prompting a rebound after a recent downturn. The community is actively discussing whether this buyback, coupled with its strategic position in hybrid cloud and enterprise AI against competitors like Broadcom/VMware, can sustain a recovery from recent declines.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render is generating buzz due to its pivotal role in the decentralized AI compute and DePIN sectors, where GPU demand is surging, leading to community discussions around its significant growth potential while navigating recent confusion surrounding the delisting of its older token.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TD Cowen Issues Pessimistic Forecast for Live Oak Bancshares (NASDAQ:LOB) Stock Price

TD Cowen decreased their price target on shares of Live Oak Bancshares from $53.00 to $51.00 and set a "buy" rating for the company in a report on Tuesday...

Live Oak Bancshares (NASDAQ:LOB) Insider Sells $378,397.00 in Stock

Live Oak Bancshares, Inc. (NASDAQ:LOB - Get Free Report) insider Courtney Spencer sold 9,700 shares of the firm's stock in a transaction dated Monday, January 26th. The stock was sold at an average...

Insider Buying: Live Oak Bancshares (NASDAQ:LOB) Insider Buys 2,595 Shares of Stock

Live Oak Bancshares, Inc. (NASDAQ:LOB - Get Free Report) insider Ewa Maria Stasiowska acquired 2,595 shares of the firm's stock in a transaction that occurred on Monday, January 26th. The shares were...

Whittier Trust Co. of Nevada Inc. Raises Position in Live Oak Bancshares, Inc. $LOB

Whittier Trust Co. of Nevada Inc. increased its holdings in Live Oak Bancshares, Inc. (NASDAQ:LOB - Free Report) by 7,761.4% in the third quarter, according to the company in its most recent Form 13F...

Live Oak Bancshares Q4 Earnings Call Highlights

Live Oak Bancshares (NYSE:LOB) highlighted record loan production, strong year-over-year growth and improved operating leverage during its fourth-quarter 2025 earnings call, while also addressing...

Live Oak Bancshares (NYSE:LOB) Trading Up 9.6% Following Earnings Beat

Live Oak Bancshares (NYSE:LOB) Trading 9.6% Higher After Strong Earnings...

Live Oak Bancshares, Inc. Reveals Increase In Q4 Bottom Line

(RTTNews) - Live Oak Bancshares, Inc. (LOB) reported earnings for its fourth quarter that Increased, from the same period last year...

Live Oak Bancshares (LOB) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Live Oak Bancshares (LOB) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Live Oak Bancshares (LOB) Beats Q4 Earnings and Revenue Estimates

Live Oak Bancshares (LOB) delivered earnings and revenue surprises of +69.64% and +16.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Live Oak Bancshares (NYSE:LOB) Posts Earnings Results

Live Oak Bancshares (NYSE:LOB - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus...

Live Oak Bancshares, Inc. is a bank holding company for Live Oak Banking Company, which operates as a national online platform for small business lending. It operates through the following segments: Banking, Fintech, and Other. The Banking segment provides financing services to small businesses nationwide in targeted industries and deposit-related services to small businesses, consumers, and other customers nationwide. The Fintech segment focuses on making strategic investments in emerging financial technology companies. The company was founded by James S. Mahan III on December 18, 2018 and is headquartered in Wilmington, NC.

Live Oak Bancshares Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$40.83
Prev Close	$40.24
Open	$40.70
Dividend Yield	0.35%
50-Day Moving Average	$36.28
Beta	1.38
Avg. Volume	390,438.35
PE Ratio	18.33

52-Week High	$42.89
52-Week Low	$22.68
Market Capitalization	$1.87B
EPS (Annual)	$2.23
Price to Book	1.63
Revenue Per Employee	$1.01M
Enterprise Value/EBITDA	N/A

LOB
Live Oak Bancshares Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LOB News

LOBLive Oak Bancshares Inc